These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 32509576)

  • 1. Targeted Therapies and Biomarkers in Small Cell Lung Cancer.
    Taniguchi H; Sen T; Rudin CM
    Front Oncol; 2020; 10():741. PubMed ID: 32509576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer.
    Keogh A; Finn S; Radonic T
    Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting DNA damage repair in small cell lung cancer and the biomarker landscape.
    Sen T; Gay CM; Byers LA
    Transl Lung Cancer Res; 2018 Feb; 7(1):50-68. PubMed ID: 29535912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mRNA expression of POU2F3 in small cell lung cancer cell lines predicts the effect of lurbinectedin.
    Matsui S; Haruki T; Oshima Y; Kidokoro Y; Sakabe T; Umekita Y; Nakamura H
    Thorac Cancer; 2022 Apr; 13(8):1184-1192. PubMed ID: 35278040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ASCL1, NEUROD1, and POU2F3 expression in surgically resected specimens, paired tissue microarrays, and lymph node metastases in small cell lung carcinoma.
    Handa T; Hayashi T; Ura A; Watanabe I; Takamochi K; Onagi H; Kishi M; Matsumoto N; Tajima K; Kishikawa S; Saito T; Takahashi K; Suzuki K; Yao T
    Histopathology; 2023 May; 82(6):860-869. PubMed ID: 36715573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Implications of Molecular Subtypes in Primary Small Cell Lung Cancer and Their Correlation With Cancer Immunity.
    Qi J; Zhang J; Liu N; Zhao L; Xu B
    Front Oncol; 2022; 12():779276. PubMed ID: 35311069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC).
    Ding XL; Su YG; Yu L; Bai ZL; Bai XH; Chen XZ; Yang X; Zhao R; He JX; Wang YY
    World J Surg Oncol; 2022 Feb; 20(1):54. PubMed ID: 35220975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heterogeneity of small cell lung cancer: biological and clinicopathological implications].
    Megyesfalvi Z; Bárány N; Valkó Z; Bugyik E; Paku S; Berta J; Lantos A; Fillinger J; Moldvay J; Bogos K; Rezeli M; Gálffy G; Lang C; Lohinai Z; Hécz R; Lovas T; Rényi-Vámos F; László V; Döme B
    Magy Onkol; 2020 Sep; 64(3):243-255. PubMed ID: 34608895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive-Stage Small-Cell Lung Cancer: Current Landscape and Future Prospects.
    Saida Y; Watanabe S; Kikuchi T
    Onco Targets Ther; 2023; 16():657-671. PubMed ID: 37551311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential subtype-specific therapeutic approaches in small cell lung cancer.
    Horvath L; Lang C; Boettiger K; Aigner C; Dome B; Megyesfalvi Z
    Curr Opin Oncol; 2024 Jan; 36(1):51-56. PubMed ID: 37865844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small cell lung cancer: Subtypes and therapeutic implications.
    Wang WZ; Shulman A; Amann JM; Carbone DP; Tsichlis PN
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):543-554. PubMed ID: 35398266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Landscape and Treatment Options of Shapeshifting Small Cell Lung Cancer.
    Gu Y; Benavente CA
    J Clin Med; 2024 May; 13(11):. PubMed ID: 38892831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular subtypes, predictive markers and prognosis in small-cell lung carcinoma.
    Zhu Y; Li S; Wang H; Ren W; Chi K; Wu J; Mao L; Huang X; Zhuo M; Lin D
    J Clin Pathol; 2023 Sep; ():. PubMed ID: 37775262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced small cell lung cancer (SCLC): new challenges and new expectations.
    Tsoukalas N; Aravantinou-Fatorou E; Baxevanos P; Tolia M; Tsapakidis K; Galanopoulos M; Liontos M; Kyrgias G
    Ann Transl Med; 2018 Apr; 6(8):145. PubMed ID: 29862234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard therapy-resistant small cell lung cancer showing dynamic transition of neuroendocrine fate during the cancer trajectory: A case report.
    Ito F; Sato T; Emoto K; Kaizuka N; Yagi K; Watanabe R; Hashiguchi MH; Ninomiya H; Ikematsu Y; Tanaka K; Domoto H; Shiomi T
    Mol Clin Oncol; 2021 Dec; 15(6):261. PubMed ID: 34790350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal pathways and precision therapy of small-cell lung cancer.
    Yuan M; Zhao Y; Arkenau HT; Lao T; Chu L; Xu Q
    Signal Transduct Target Ther; 2022 Jun; 7(1):187. PubMed ID: 35705538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCLC-State of the Art and What Does the Future Have in Store?
    Kahnert K; Kauffmann-Guerrero D; Huber RM
    Clin Lung Cancer; 2016 Sep; 17(5):325-333. PubMed ID: 27397481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts.
    Lantuejoul S; Fernandez-Cuesta L; Damiola F; Girard N; McLeer A
    Transl Lung Cancer Res; 2020 Oct; 9(5):2233-2244. PubMed ID: 33209646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models.
    Lissa D; Takahashi N; Desai P; Manukyan I; Schultz CW; Rajapakse V; Velez MJ; Mulford D; Roper N; Nichols S; Vilimas R; Sciuto L; Chen Y; Guha U; Rajan A; Atkinson D; El Meskini R; Weaver Ohler Z; Thomas A
    Nat Commun; 2022 Apr; 13(1):2023. PubMed ID: 35440132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer.
    Sen T; Takahashi N; Chakraborty S; Takebe N; Nassar AH; Karim NA; Puri S; Naqash AR
    Nat Rev Clin Oncol; 2024 Jul; ():. PubMed ID: 38965396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.